402 related articles for article (PubMed ID: 16625859)
41. Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells.
Corleto VD; Severi C; Romano G; Tattoli I; Weber HC; Stridsberg M; Rindi G; Campanini N; Tomassoni F; Pagotto U; Coy DH; Jensen RT; Delle Fave G
Neurogastroenterol Motil; 2006 Mar; 18(3):217-25. PubMed ID: 16487413
[TBL] [Abstract][Full Text] [Related]
42. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
[TBL] [Abstract][Full Text] [Related]
43. Somatostatin analogs and radiopeptides in cancer therapy.
Froidevaux S; Eberle AN
Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin and somatostatin receptors in the immune system: a review.
ten Bokum AM; Hofland LJ; van Hagen PM
Eur Cytokine Netw; 2000 Jun; 11(2):161-76. PubMed ID: 10903795
[TBL] [Abstract][Full Text] [Related]
45. Cortistatin--functions in the central nervous system.
de Lecea L
Mol Cell Endocrinol; 2008 May; 286(1-2):88-95. PubMed ID: 18374474
[TBL] [Abstract][Full Text] [Related]
46. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
Zatelli MC; Piccin D; Vignali C; Tagliati F; Ambrosio MR; Bondanelli M; Cimino V; Bianchi A; Schmid HA; Scanarini M; Pontecorvi A; De Marinis L; Maira G; degli Uberti EC
Endocr Relat Cancer; 2007 Mar; 14(1):91-102. PubMed ID: 17395978
[TBL] [Abstract][Full Text] [Related]
47. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
[TBL] [Abstract][Full Text] [Related]
48. Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.
Yang SK; Chen C
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1221-7. PubMed ID: 17892506
[TBL] [Abstract][Full Text] [Related]
49. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
Gonzalez-Rey E; Delgado M
Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
[TBL] [Abstract][Full Text] [Related]
50. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
[TBL] [Abstract][Full Text] [Related]
51. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system.
Dalm VA; van Hagen PM; van Koetsveld PM; Langerak AW; van der Lely AJ; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2003 Jan; 88(1):270-6. PubMed ID: 12519865
[TBL] [Abstract][Full Text] [Related]
52. Identification of the receptors for somatostatin (SST) and cortistatin (CST) in chickens and investigation of the roles of cSST28, cSST14, and cCST14 in inhibiting cGHRH1-27NH2-induced growth hormone secretion in cultured chicken pituitary cells.
Meng F; Huang G; Gao S; Li J; Yan Z; Wang Y
Mol Cell Endocrinol; 2014 Mar; 384(1-2):83-95. PubMed ID: 24418361
[TBL] [Abstract][Full Text] [Related]
53. Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
Reubi JC; Schaer JC; Markwalder R; Waser B; Horisberger U; Laissue J
Yale J Biol Med; 1997; 70(5-6):471-9. PubMed ID: 9825475
[TBL] [Abstract][Full Text] [Related]
54. Somatostatin receptors in the gastrointestinal tract in health and disease.
Reubi JC
Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
[TBL] [Abstract][Full Text] [Related]
55. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
Kumar U
J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
[TBL] [Abstract][Full Text] [Related]
56. Functional role of somatostatin receptors in neuroendocrine and immune cells.
Hofland LJ; van Hagen PM; Lamberts SW
Ann Med; 1999 Oct; 31 Suppl 2():23-7. PubMed ID: 10574151
[TBL] [Abstract][Full Text] [Related]
57. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review.
Van Op den Bosch J; Adriaensen D; Van Nassauw L; Timmermans JP
Regul Pept; 2009 Aug; 156(1-3):1-8. PubMed ID: 19362110
[TBL] [Abstract][Full Text] [Related]
58. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
[TBL] [Abstract][Full Text] [Related]
59. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
[TBL] [Abstract][Full Text] [Related]
60. Radiolabelled somatostatin analog therapy in prostate cancer: current status and future directions.
Liu Y
Cancer Lett; 2006 Jul; 239(1):21-6. PubMed ID: 16126334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
